Back
Monopar Therapeutics Stock Price Chart

Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78
MNPR
Monopar Therapeutics
Last Price:
$51.19
Seasonality Move:
-10.68%
7 Day Trial
ALL ACCESS PASS
$
7

BOXABL Announces New $20,000 House
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular here. This is a message from Boxabl-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.78 | Buy |
20-day SMA: | 38.55 | Buy |
50-day SMA: | 29.75 | Buy |
200-day SMA: | 11.84 | Buy |
8-day EMA: | 46.63 | Buy |
20-day EMA: | 40.26 | Buy |
50-day EMA: | 31.51 | Buy |
200-day EMA: | 16.24 | Buy |
Monopar Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.28 | Buy |
Relative Strength Index (14 RSI): | 71.86 | Buy |
Chaikin Money Flow: | 26496 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.34 - 45.08) | Buy |
Bollinger Bands (100): | (8.04 - 32.74) | Buy |
Monopar Therapeutics Technical Analysis
Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 51.89 while MNPR 8-day simple moving average is 46.78, which is a Buy signal.
-
The stock price of MNPR is 51.89 while Monopar Therapeutics 20-day SMA is 38.55, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 29.75 while MNPR share price is 51.89, making it a Buy technically.
-
MNPR stock price is 51.89 and Monopar Therapeutics 200-day simple moving average is 11.84, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
78
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $51.89. The Score for MNPR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
273.9M
Price in USD:
51.89
Share Volume:
103K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.60
Buy
78
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 51.89 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 51.89 while MNPR 8-day exponential moving average is 46.63, which is a Buy signal.
-
The stock price of MNPR is 51.89 while Monopar Therapeutics 20-day EMA is 40.26, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 31.51 while MNPR share price is 51.89, making it a Buy technically.
-
MNPR stock price is 51.89 and Monopar Therapeutics 200-day simple moving average is 16.24, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 6.28, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 71.86, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (26.34 - 45.08), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (8.04 - 32.74), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.